Photo taken from Oncology Brothers/X
Mar 8, 2024, 23:18
Nivo/Gem/Cis now FDA Oncology approved for 1L metastatic bladder cancer based on CM901 – Oncology Brothers
Oncology Brothers made the following post on X:
“Nivo/Gem/Cis now FDA Oncology approved for 1L metastatic bladder cancer based on CM901:
- Improved OS w/ Nivo (HR 0.78) 21.7mos Vs 18.9mos
- ≥ Gr3 AEs in 62% Vs 52%
- New Option (if a patient is not a candidate for EV302)”
Source: Oncology Brothers/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 14:05
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10